Lillie James Woodruff 4
4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Lillie James Woodruff
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-10+8,333→ 8,333 totalExercise: $13.98Exp: 2028-05-10→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.
- [F2]The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).